Trial Profile
A Study of Docetaxel and Lobaplatin vs. Docetaxel and Carboplatin Combination Regimen in Patients With Platinum-sensitive (>6 Months) Relapsed Ovarian Cancer
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 16 May 2013
Price :
$35
*
At a glance
- Drugs Docetaxel (Primary) ; Lobaplatin (Primary) ; Carboplatin
- Indications Ovarian cancer
- Focus Adverse reactions
- 16 May 2013 New trial record